Dr. Radka Obermannova, Ph.D., is a Consultant Medical Oncologist at the Department of Comprehensive Cancer Care at Masaryk Memorial Cancer Institute in Brno, Czech Republic. She is specialized in the treatment of patients with gastrointestinal cancers. She graduated from Masaryk University in Brno and completed her Medical Oncology training and Ph.D. study at the same university. Her scientific focus on GI cancer inspired her for a subsequent research career, namely in her interest in optimizing multimodal gastric cancer treatment involving predictors of treatment response.

Dr. Obermannova was GI inpatient ward head physician and since 2012 serves as a chief physician of a Phase I Unit. She is involved in drug development as a principal investigator and co-investigator of phase I-III clinical trials. Dr. Obermannova is a co-author of national guidelines on oesophageal and gastric cancer, and she is also co-author of ESMO oesophageal cancer treatment guidelines.

Dr. Obermannova is an active member of the ESMO Gastrointestinal Non-Colorectal Faculty Group and co-Chair of the EORTC Individualized therapy Task Force at the Gastrointestinal Tract Cancer Working Group. She is also a member of the International Gastric Cancer Association (IGCA) and the Czech Society for Oncology.